retatrutide chemical formula | GLP-1R/GIPR/GCGR ligand | Sterile Buy Retatrutide (60 mg) |

Codes run in TriNetX database

In a 48-week phase II clinical trial conducted on patients with type 2 diabetes and obesity, treatment with a dose of 10 mg/kg of bimagrumab resulted in a significant reduction in fat mass by 20.5% (compared to 0.5% in the placebo group), while lean body mass increased by 3.6% (as opposed to a decrease of 0.8% in the placebo group), leading to an overall body weight reduction of -6.5%, which was substantially better than the -0.8% observed in the placebo group

Schedule your consultation today and take the next step toward sustainable, long-term success

Digestive issues Medications like orlistat may cause gastrointestinal distress, including diarrhea, nausea, bloating, and fatty stools

Do not rely on general guidance for other peptide medicines as a substitute for product-specific instructions